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Summary.-Transformation of rat embryo fibroblasts in vitro has been investigated
using initiation with either benzo(a)pyrene (BaP), 7,12-dimethylbenz(a)anthracene
(DMBA) or benzo(e)pyrene (BeP) and promotion with either phorbol ester (TPA) or
croton oil (Cr.Oil). The criteria used to assess in vitro transformation were (a) the
efficiency of cloning in liquid medium, (b) abnormal cellular morphology and (c) the
development of malignant tumours following s.c. inoculation of newborn rats.
The results show that the cloning efficiency, which remained low in the control cells,
was increased to a variable extent in the treated groups. Transformation occurred
in all groups, but occurred earliest in cells that were initiated and promoted. Initia-
tion with DMBA or BaP and promotion with TPA or Cr.Oil led to the earliest
acquisition of malignancy. Correlations were found between the transformation of
cells in vitro and the acquisition of malignant potential, and between the carcinogenic
action of the compounds in vitro and their action in vivo, but cloning efficiency was
not a reliable indicator of in vitro transformation or of malignancy. In most cases
in vitro transformation appeared to precede the acquisition of malignancy, but in two
cases it occurred later. The studies also show that BeP, which is a tumour initiator
in vivo, also acts in this way in vitro. The conclusion drawn from a discussion of
these results and of two-stage carcinogenesis in vivo is that two-stage carcinogenesis
can be reproduced in tissue culture; this model may be useful in studies of those
mechanisms of chemical carcinogenesis that involve the processes of initiation and
promotion.
FRIEDEWALD AND Rous (1944) first
defined that " carcinogenesis was com-
posed of an initiating process, responsible
for the conversion of normal into latent
tumour cells, and a promoting process,
whereby these latent tumour cells were
made to develop into actual tumours ".
The real development of 2-stage carcino-
geinesis was due to Berenblum, who origi-
nally used the term " precarcinogenic
actioil " for the initiation and " epicar-
cinogenic action" for the promotion, but
in the interest ofuniformity he later adop-
ted the terms " initiation " and " promo-
tion " (Berenblum, 1941, 1974; Berenblum
and Shubik, 1947, 1949).
The early experimental work on co-
carcinogenesis was carried out exclusively
in vivo. However, in vivo techniques are
not suitable for examining the phenomena
at the cellular level. Since the malignant
transformation of fibroblasts can be in-
duced in vitro by chemicals (Berwald and
Sachs, 1963; Chen and Heidelberger, 1969:
DiPaolo. Donovan and Nelson, 1969), the
methods of tissue culture can be applied
to studies of the mechanisms involved in
chemical carcinogenesis, just as they have
been applied to viral oncogenesis (Mac-
Pherson, 1970). Our aim has therefore
been to reproduce in vitro the phenomenon
of 2-stage carcinogenesis.
We have previously reported an ac-
celeration of the transformation of rat
fibroblasts in vitro after initiation with
benzo(a)pyrene, followed by a promoting
treatment with phorbol ester (Lasne,
1973; Lasne, Gentil and Chouroulinkov,TWO-STAGE CARCINOGENESIS
1974). Since in these initial experiments
transformation of the control and of the
initiated cells closely followed transforma-
tion of the initiated and promoted cells,
some problems remained to be solved.
The present results extend and comple-
ment the previous ones and allow some
more definite conclusions to be drawn.
MATERIALS AND METHODS
Cell cultures
The experiments were carried out with rat
embryo fibroblasts prepared from pathogen-
free Wistar rats, from our own breeding
colony. Primary cultures were prepared
from 14-day-old embryos that had been
aseptically removed, washed twice in phos-
phate-buffered saline (PBS) and minced in
small pieces. The tissue fragments were
dispersed for 5 min in PBS with a magnetic
stirring rod and then submitted to the action
of 0 25% trypsin, both operations being
carried out at 37°C. The supernatants from
the first 20-min digestion were pooled after
the action ofthe trypsin had been stopped by
the addition of calf serum. The cells were
filtered through sterile gauze and centrifuged
for 5 min at 1000 rev/min. The cell pellets
were resuspended in Dulbecco's growth
medium H16 (GIBCO) supplemented with
10% foetal calfserum (GIBCO) and were used
to prepare primary cultures. After counting
with a Thomas haemocytometer, the cells
were diluted to 0 5 x 106/ml and seeded in
10-cm plastic Petri dishes (Falcon Plastics),
each dish receiving 10 ml of the cell suspen-
sion (5 X 106 cells per dish). They were
incubated at 37°C in a humidified atmosphere
of air with 10% Co2. Every 5 days the cells
were collected using a 0.25% trypsin solution
and subcultured at 105 cells/ml of medium.
Chemicals
Dimethylbenz(a)anthracene (DMBA)
(Fluka Co., Switzerland), benzo(a)pyrene
(BaP) (Schuchardt Co., Munich, Germany)
and benzo(e)pyrene (BeP) (K and K Labora-
tories Inc., Plainview, N.Y., U.S.A.) were
used as initiators. They were purified before
use bythin-layer chromatography onsilicagel,
using benzene as solvent.
Croton Oil (Cr.Oil) (Schuchardt Co.,
Munich, Germany) and 12-0-tetradecanoyl-
phorbol-13-acetate (TPA), kindly donated
by Professor E. Hecker (Heidelberg, Ger-
many), were used as promoters.
All substances were added to the growth
medium in acetone solution. The final
concentration ofsolvent in the medium never
exceeded 0-5%, a concentration which did not
affect cell growth or morphology.
Treatment
Initiation.-One day after seeding, the
cells from the third passage (P3) received the
initiator: DMBA (Exp. I), BaP or BeP
(Exp. II). DMBA was added as a single dose
of 0 5 ,ug/ml of medium for 24 h, BaP and
BeP at a concentration of 1 ,ug/ml ofmedium
for 6 h only. After treatment with initiator,
cells were immediately washed with normal
medium and reincubated in fresh medium at
37°C until treated with either promoter or
solvent. A second series ofdishes, containing
cells from the same P3, received an initial
treatment with solvent only.
Promotion.-The promoting treatment
started 7 days after the initiation treatment,
using either TPA or Cr.Oil added at a final
concentration of0.01 ,ug/ml ofmedium. The
promoters were added as solutions in acetone
at every passage until the end of the experi-
ments. The control cells received the solvent
only.
Transformation assay
The effects of the different treatments on
the cells, were estimated, at intervals, as
shown in Fig. 5. The tests consisted of
cloning in liquid medium, the results being
expressed by (a) the cloning efficiency (CE),
and (b) the transformation efficiency (TE),
and of the s.c. inoculation of the cells into
newbornrats expressed by (c) themalignancy.
Cloning efficiency (CE).-Tissue culture
cells, when sparsely seeded, tend to develop
into colonies (Puck and Marcus, 1955). After
trypsinization, 200 cells from each group were
suspended in 2 ml of Dulbecco's medium
supplemented with 20% foetal calfserum and
were plated in 60-mm plastic Falcon Petri
dishes and incubated at 37°C in an atmos-
phere of air with 10% CO2. Ten days later
the colonies were fixed in methanol and
stained with Giemsa. The percentage of
plated cells developing into colonies is
indicative of the cloning efficiency (CE) of the
cells.
Transformation (T).-The transformation
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in these experiments was recognized by the
abnormal morphological characteristics of
the colonies, such as a loss of cell orientation
and a piling-up of the cells in a random
criss-cross pattern (Berwald and Sachs, 1965).
The percentage of atypical colonies repre-
sented the transformation efficiency (TE) of
the culture.
Malignancy.-The malignancy ofthe cells
was determined by inoculation into animals.
The treated and control cells from different
passages were inoculated s.c. into the cranial
region of 2-day-old isologous Wistar rats,
each animal receiving 2 or 3 x 106 cells as a
suspension in 0.05 ml of culture medium.
The animals were subsequently examined
twice a week for palpable tumour formation,
for a period ofat least 6 months. Systematic
histological examination was performed on
all tumours; these appeared to be fibro-
sarcomas.
RESULTS
Cloning efficiency
In Exp. I (Fig. 1) the CE of the
solvent control cells remained low; the CE
of the cells treated with DMBA or with
DMBA + TPA increased at P32-P36,
whereas that of the TPA treated cells
increased rapidly at P16. In Exp. II
(Fig. 2) the solvent controls and the
BaP-treated cells retained a low CE.
With the other treatments, the CE
showed variation depending on the treat-
passages
FIG. 2.-Cloning efficiency of rat embryo cells
during 2-stage carcinogenesis in vitro.
Initiators: BaP and BeP, promoter: Cr.Oil
(= CrO).
ment and on the number of passages. It
increased significantly at P49-P54 with
the cells treated with Cr.Oil, BaP + Cr.
Oil and BeP + Cr.Oil.
Transformation
Transformation of the control cells (or
" spontaneous transformation ") occurred
after P49 in both experiments (Figs. 3 and
4). Transformation of cells treated with
BaP and BeP (Fig. 4) occurred at approxi-
mately the same time as that of the
controls, whereas transformation of the
Cr.Oil-treated cells was slightly delayed.
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FIG. 3.-Transformation of rat embryo cells
during 2-stage carcinogenesis in vitro.
Initiator: DMBA, promoter: TPA.
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FIG. 1. Cloning efficiency (CE) of rat embryo
cells during 2-stage carcinogenesisin vitro.
Initiator: DMBA, promoter: TPA.
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FIG. 4.-Transformation of rat embryo cells
during 2-stage carcinogenesis in vitro.
Initiators: BaP and BeP, promoter: Cr.Oil
(- CrO).
On the other hand, transformation was
markedly accelerated for cells treated with
DMBA + TPA, BaP + Cr.Oil and BeP
+ Cr.Oil (Figs. 3 and 4). Transformation
of the DMBA-treated and TPA-treated
cells was also accelerated, and occurred
soon after that of the (DMBA + TPA)-
treated cells.
DMBA
Exp.
Malignancy
Malignancy of the control cells (or
"spontaneous malignant transforma-
tion ") was demonstrated at P55 (275 days
of culture) for Exp. I (Fig. 5), and at P67
(335 days) for Exp. II (Fig. 5). In
contrast, the malignancy of the cells
treated with DMBA + TPA and BaP +
Cr.Oil appeared respectively at P36 (180
days) and P28 (140 days). Other treat-
ments gave results between these 2
extremes. In Exp. I, the malignancy of
the cells treated with TPA and DMBA
alone was demonstrated respectively at
P40 (200 days) and at P46 (230 days).
These transformation times were close to
those of (DMBA + TPA)-treated cells
(P36) and the difference between the
DMBA + TPA treatment and the TPA-
only treatment cannot be considered as
significant.
In Exp. II (Fig. 5) the malignancy of
BaP-treated cells was demonstrated at
P46 (230 days); the malignancy of Cr.Oil-
treated cells at P51 (255 days) and that of
BeP + Cr.Oil and BeP-treated cells at
P61 (305 days) ofthe cultures. These data
M
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FIG. 5.-Transformation of rat embryo cells in tissue culture by chemicals. Experimental protocol
showing initiation with DMBA, BaP or BeP followed by promotion with TPA or Cr.Oil. Cell
transformation data obtained by cloning in liquid medium: and malignancy from the results of
inoculation ofcells into newborn animals. * M = number of tumours per total number of animals
inoculated. T = transformed clones/100.
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TABLE.-Effect ofInitiation andPromotion on the Transformation and Malignancy ofRat
Cells in Culture, and on the Acceleration of these Phenomena
Treatment
Initiation Promotion
DMIBA TPA
DMBA
TPA
BaP Cr.Oil
BaP
BeP Cr.Oil
BeP
-- Cr.Oil
T20
255
160
175
170
255
AT20
95
80
85
120 135
270 (-15)
145 110
245 10
315 (-60)
M
275
180
230
200
335
140
230
305
305
255
AM M -T20
__ 20
95 20
45 55
75 30
80
195 20
105 (-40)
30 160
30 60
80 (-60)
T20-Culture time (in days) for 20% transformation.
AT20 Acceleration of T20 = T20 controls -T20 treated
M--Culture time (in days) for malignancy.
AM Acceleration of M = Mcontrois - Mtreated-
are of course approximate, since there
were variations in the number of animals
that developed tumours, stemming pre-
sumably from variations in themalignancy
of the injected cells. We observed that
after the first positive inoculation there
was a small number of tumours, but these
only became apparent after a long latent
period. With subsequent inoculations all
animals developed tumours, and the
latent period became shorter, even if the
number of cells inoculated was lower
(Table). The malignant potential of
treated cells can thus be estimated from
the length of the latent period that pre-
cedes tumour development.
DISCUSSION
Cloning efficiency
Cloning efficiency, as well as the occur-
rence of morphologically abnormal
colonies, are both generally accepted
criteria of cellular transformation after
treatment withchemical carcinogens (Puck
and Marcus, 1955). Our results with rat
fibroblasts, however, show no correlation
between the appearance of an increase in
CE and morphological transformation.
For example, CE increased before trans-
formation (with TPA), accompanied trans-
formation or immediately followed it
(with DMBA + TPA, BaP, BeP, Cr.Oil,
and controls), or increased later (BaP +
Cr.Oil, BeP + Cr.Oil) (Figs 1 and 2). In
addition, there did not appear to be a
correlation between the appearance of an
increase in CE and in vivo malignancy:
CE increased before malignancy (with
BeP + Cr.Oil, DMBA, TPA, Cr.Oil), at
the same time or immediately after cell
malignancy (controls of Exp. I, DMBA +
TPA), or much later (BaP + Cr.Oil). CE
also either decreased (after treatment with
BaP) or remained at the same level
throughout the experiments (after BeP
and the controls of Exp. II).
These results show that the level ofCE
does not have the same significance in this
type of study as transformation or malig-
nancy, and that different treatments,
given either alone or in combination, can
influence the CE of rat embryonic cells in
different ways which do not appear to be
related to the other 2 parameters ex-
amined.
Transformation and malignancy
Abnormal colony morphology is con-
sidered as a criterion of transformation,
especially with studies using Syrian ham-
ster cells (Berwald and Sachs, 1963) in
which transformation can vary from 0 to
25% depending on the treatment and on
the experimental conditions (Berwald and
Sachs, 1965; DiPaolo et al., 1969;
DiPaolo, Donovan and Nelson, 197 la;
Exp. I
Exp. II
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1971b; Huberman et al., 1972). Trans-
formation of rat cells has been studied
mostly by looking for the appearance of
transformed foci (Freeman, Igel and
Price, 1975). Current studies show that,
after cloning, the frequency with which
transformed colonies of rat cells is seen is
variable, and that the transformed state
is not stable when this frequency is below
15%, although this becomes more stable
as soon as this value approaches 20%.
Below 15%, normal cells may inhibit the
manifestation of transformation (Berwald
and Sachs, 1965). The 20% transforma-
tion level (T20) then seems to be the
critical threshold oftransformation for rat
cells, above which there is a constant
increase. If a line is drawn parallel to the
abscissa at the 20% mark on the ordinate
(Figs 3 and 4), it will cut the transforma-
tion curves at a point representing a
number of passages or days in culture.
T20 can therefore serve as a reference
point for transformation measurements
and, despite the possible variations, it
would permit a quantitative evaluation of
the transforming effects ofthe treatments.
Since control cells also become trans-
formed, one can also calculate the ac-
celeration oftransformation (AT20) caused
by a compound, by taking the difference
between the T20 of the control cells and
the T20 of the treated cells (AT20 =T2C
- T20t) expressed in days (Table).
Malignancy reflects the capacity of
transformed cells to form tumours after
their inoculation into isologous animals.
It is therefore possible to calculate, in
days, the acceleration of the acquisition
of malignancy (AM) as the difference
between the time at which the control
cells first exhibit malignancy (Mc) and the
time at which malignancy can first be
demonstrated for treated cells (Mt);
(AM - M, - Mt) (Table).
This manner of presenting the results
permits us to examine correlations be-
tween transformation (T) and malignancy
(M) and between the carcinogenic action
of the substances in vivo and their action
in vitro. During these studies, we noted
50
that in 8 cases, cells showed morphological
transformation before they exhibited
malignancy, but that in 2 cases (BaP-
treated and Cr.Oil-treated) morphological
transformation was not seen until after
malignancy. Secondly, the BeP + Cr.Oil
treatment significantly accelerated cell
transformation (110 days) but altered the
onset of malignancy to a lesser extent
(30 days), whereas Cr.Oil-alone retarded
transformation (-60 days) and acceler-
ated malignancy (80 days). These data
suggest that even though transformation
generally precedes malignancy, the 2
phenomena are not necessarily linked as
has been shown with guinea-pig cells
(Evans and DiPaolo, 1975).
When the results (Table) were analysed
as a function of the carcinogenic action of
the substances used, we noted that the
correlation was good for DMBA and BaP
alone or combined with TPA or Cr.Oil.
The action of TPA alone in vitro is as in
vivo. Besides its co-carcinogenic activity,
TPA exhibits a weak but definite carcino-
genic activity (Chouroulinkov and Lazar,
1974; Hecker, 1966, 1968).
The acceleration of transformation by
BeP + Cr.Oil suggests that BeP is an
initiator, which is in accord with the
results already observed in vivo (Scribner,
1973), but these results need to be con-
firmed in further studies. Cr.Oil treat-
ment gave some disturbing results. The
acceleration of malignancy by Cr.Oil can
be attributed to its weak tumorigenic
activity (Boutwell, Bosch and Rusch,
1957). The accelerating action on cell
malignancy and its retarding effect on
transformation are both suppressed when
the cells are pretreated with BeP. This
observation, and the fact that TPA has
no effect on the CE of the cells initiated
with DMBA (Table) indicate that the
cells pretreated with DMBA or BeP do not
respond to Cr.Oil and TPA like normal
cells.
If the action of BaP and BeP as ini-
tiators is examined, it seems that the 2
hydrocarbons acted on transformation
" sites ", since in both cases Cr.Oil
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accelerated transformation (T). In con-
trast, the " sites " of the initiation of
malignancy were affected by BaP but not
by BeP, since Cr.Oil accelerated malig-
nancy in the first case and not in the
second. We may conclude that the sites
for transformation are different from those
involved in malignancy. Other workers
have suggested that tumour promoters
act in vitro by releasing cells from contact
inhibition (Sivak and van Duuren, 1967,
1970).
Co-carcinogenesis
Berenblum (1974) recently defined the
"basic requirements " for the existence
of a 2-stage carcinogenesis process, which
we have tried to apply to our tissue culture
experiments.
1. The 2 separate actions, initiation
and promotion, should not overlap
in time.
Our experiments were designed in such
a way that the initiation step, lasting 6
or 24 h, was separated from the first pro-
motion step by 7 days (see Fig. 5).
2. Neither action alone should be
carcinogenic.
As shown, the results do not appear to
satisfy this condition, because of the
spontaneous transformation of the cells
and the positive reactions obtained with
both the "initiators" and the " pro-
moters ". However, one should not
forget that the cellular model differs from
the animal model because of the earlier
" spontaneous transformation " of the
control cells. The death of the animal
normally prevents one from observing
" spontaneous " carcinogenesis in skin
cells, and even ifthis does occur, we do not
know the latent period. However, if we
stop our in vitro experiments earlier,
before spontaneous transformation, the
cellular model becomes much more analo-
gous to the animal model.
The positive effect ofthe initiators and
promoters is to a certain extent a problem
of dosage. Although the initiating doses
of DMBA and BaP and the pronloting
doses of TPA and Cr.Oil are known for
mouse skin, we did not know the appro-
priate doses to use with cells in culture
when these experiments were started.
The results of Exp. I show that the
initiating dose of DMBA was too high;
those ofExp. II seem more clear-cut, even
if the initiating dose of BaP was still too
high.
3. Extending the interval between the
2 actions should not alter the
tumour yield.
For tissue culture experiments, this
condition should be modified to read: the
acceleration of malignancy should not be
modified by the interval between the 2
treatments. In an earlier experiment with
BaP and TPA (Lasne et al., 1974),
promotion was begun 35 days after
initiation, and the results were similar to
those presented here.
4. The ultimate tumour yield should
be quantitatively related to the dose
ofinitiator, whiletheefficacyandthe
speed of tumour induction should
be determined by the promoter.
To respond to this condition, one must
see to what extent a qualitative relation-
ship exists between the cutaneous lesions
arising during carcinogenesis in vivo and
the cellular modifications seen in culture.
On mouse skin, benign tumours develop
which may later evolve into malignant
tumours, especially if the treatment is
continued. However, malignant tumours
can also develop directly. Similarly, in
cell culture, morphological transformation
usually appears before the cells can be
shown to be malignant, but the latter can
sometimes be demonstrated prior to
morphological transformation (Table).
According to the 4th condition listed
as a requirement for 2-stage carcino-
genesis, the number of tumours would be
determined by the initiation and the latent
period for tumourformationbypromotion.
In culture, initiation actually influences
both the amount of cell transformation
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(expressed as a percentage) and the
number of malignant cells, which plays an
important role in tumour development.
Promotion in vitro affects both the latent
period, and the acceleration time.
The results presented here show that
the malignant transformation of cells in
2 stages is reproducible in tissue culture,
as has been demonstrated in another
experimental system using mouse cells
(Mondal, Brankow and Heidelberger,
1976). These authors concluded that the
promoters were not acting by selecting
transformed cells and that it should be
possible to study the mechanisms involved
in initiation and promotion in an experi-
mental in vitro system more simply than
in the whole animal: cultured cells can be
considered as a model system that will
facilitate further investigations on the
carcinogenic or co-carcinogenic actions of
environmental agents.
We wish to acknowledge the excellent
technical assistance ofMrs F. Chauveheid.
We are indebted to Dr P. L. Grover
(Chester Beatty Research Institute, Lon-
don) for advice.
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